Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Shares Outstanding (Diluted Average) (2016 - 2017)

Historic Shares Outstanding (Diluted Average) for UroGen Pharma (URGN) over the last 2 years, with Q4 2017 value amounting to $13.6 million.

  • UroGen Pharma's Shares Outstanding (Diluted Average) rose 6412.31% to $13.6 million in Q4 2017 from the same period last year, while for Dec 2017 it was $13.6 million, marking a year-over-year increase of 6412.31%. This contributed to the annual value of $13.6 million for FY2017, which is 6412.31% up from last year.
  • UroGen Pharma's Shares Outstanding (Diluted Average) amounted to $13.6 million in Q4 2017, which was up 6412.31% from $8.3 million recorded in Q4 2016.
  • UroGen Pharma's Shares Outstanding (Diluted Average)'s 5-year high stood at $13.6 million during Q4 2017, with a 5-year trough of $8.3 million in Q4 2016.